Recombine Garners $3,300,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=44f24532-0f52-47ad-a8c9-d323ea696d54 - Date
3/5/2014 - Company Name
Recombine - Mailing Address
32 Union Square East New York, NY 10003 - Company Description
Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine’s genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers. - Website
http://www.recombine.com - Transaction Type
Venture Equity - Transaction Amount
$3,300,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
FirstMark Capital - Venture Investor
Undisclosed
